cancer pain
Conditions
Interventions
Experimental group with Phlegm-dampness syndrome type cancer pain:Honeysuckle and Baizhi Beverage
Control group with:Honeysuckle and Baizhi Beverage Placebo
Experimental group with Qi deficiency and phlegm dampness syndrome cancer pain:Ginseng and Concha Ostreae Beverage
Control group with Qi deficiency and phlegm dampness syndrome cancer pain:Ginseng and Concha Ostreae Beverage Placebo
Sponsors
Affiliated Hospital of Shandong University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Cancer pain was subject to the following inclusion criteria: (1) 18 = age = 75 years old, gender is not limited; (2) Cancer patients with a clear pathologic diagnosis (conforming to the clinical diagnosis is also acceptable); (3) 4 = NRS = 6, KPS score = 40; (4) Expected survival period of more than 3 months. (5) Good compliance and signing of informed consent before enrollment. (6) Subjects agreed not to participate in other intervention studies during the treatment period. In addition, the following criteria should be met: (1) The diagnostic criteria of cancerous pain and the TCM diagnosis of "phlegm-dampness syndrome" should be met. (2) Those who meet the diagnostic criteria of cancer pain and the TCM diagnostic classification of "Qi deficiency and phlegm dampness syndrome".
Exclusion criteria
Exclusion criteria: (1) Subjects with known or suspected allergies to known components of the study drug. (2) Persons who are unable to understand, read, and complete the Patient Self-Assessment Scale due to their level of knowledge or intelligence. (3) Women of childbearing age who are pregnant, breastfeeding, or inadequately contracepted. (4) Those who have received other treatment or participated in other therapeutic clinical trials within 30 days. (5) Any unstable condition or condition that may jeopardize the safety of the patient and his/her compliance with the study (persons with severe mental illness such as schizophrenia, persons with significant traumatic damage such as surgical treatment within 30 days, persons with comorbidities of severe cardiovascular system diseases, cerebrovascular system diseases, active hepatitis, severe abnormalities of hepatic and renal functions, or other acute life-threatening illnesses). (6) Non-cancer pain (pain related to tumor emergencies such as pathological fracture, infection, visceral obstruction, visceral perforation, etc., surgery, and medically induced pain such as surgery, puncture, chemotherapy, radiotherapy, etc.). (7) Persons judged by the investigator to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numeric Rating Scale for Pain Level (NRS score);Chinese medicine evidence efficacy score; | — |
Countries
China
Contacts
Public ContactLiu Zhaidong
Affiliated Hospital of Shandong University of TCM
Outcome results
None listed